» Articles » PMID: 16207347

Clinical and Laboratory Characteristics of Drug-induced Vasculitic Syndromes

Overview
Publisher Biomed Central
Specialty Rheumatology
Date 2005 Oct 7
PMID 16207347
Citations 12
Authors
Affiliations
Soon will be listed here.
Abstract

Clinical recognition of drug-induced vasculitic and lupus-like syndromes is very important because continued use of the offending drug can lead to irreversible and life-threatening vasculitic organ damage (e.g. end-stage renal disease or pulmonary haemorrhage). Withdrawal of the drug often leads to spontaneous recovery, meaning that immunosuppressive therapy can be avoided. The presence of myeloperoxidase-antineutrophil cytoplasmic antibodies, IgM anticardiolipin antibody, and antihistone antibodies in combination was found to be characteristic of drug-induced vasculitic syndromes caused by the antithyroid drugs propylthiouracil and methimazol. Clinically, skin vasculitis and arthralgias predominated and renal vasculitis was rare.

Citing Articles

Propylthiouracil-induced vasculitis with alveolar hemorrhage after 31 years of treatment: a case report.

Khalaf R, Mhesin D, Abu Salim H, Taha S, Abed W Clin Diabetes Endocrinol. 2024; 10(1):42.

PMID: 39587631 PMC: 11587566. DOI: 10.1186/s40842-024-00215-3.


Vasculitis-like Palpable Purpuric Rash Induced by Decapeptyl in a Pediatric Patient Diagnosed Central Precocious Puberty.

Galip N, Ankay N, Bundak R J Clin Res Pediatr Endocrinol. 2021; 15(3):307-311.

PMID: 34763385 PMC: 10448555. DOI: 10.4274/jcrpe.galenos.2021.2021.0205.


Doxycycline-Induced Antinuclear Antibody and Antineutrophil Cytoplasmic Antibody Associated Vasculitis: A Case Report and Literature Review.

Wriston D, Norfolk E, Smith L, Chen G, Bulbin D Case Rep Rheumatol. 2020; 2020:3853671.

PMID: 32908768 PMC: 7474355. DOI: 10.1155/2020/3853671.


Drug-induced anti-neutrophil cytoplasmic antibody-associated vasculitis.

Weng C, Liu Z Chin Med J (Engl). 2019; 132(23):2848-2855.

PMID: 31856057 PMC: 6940077. DOI: 10.1097/CM9.0000000000000539.


Drug-induced glomerular disease: immune-mediated injury.

Hogan J, Markowitz G, Radhakrishnan J Clin J Am Soc Nephrol. 2015; 10(7):1300-10.

PMID: 26092827 PMC: 4491282. DOI: 10.2215/CJN.01910215.


References
1.
Thong H, Chu C, Chiu H . Methimazole-induced antineutrophil cytoplasmic antibody (ANCA)-associated vasculitis and lupus-like syndrome with a cutaneous feature of vesiculo-bullous systemic lupus erythematosus. Acta Derm Venereol. 2002; 82(3):206-8. DOI: 10.1080/00015550260132523. View

2.
Choi H, Merkel P, Walker A, Niles J . Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum. 2000; 43(2):405-13. DOI: 10.1002/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5. View

3.
Herlin T, Birkebaek N, Wolthers O, Heegaard N, Wiik A . Anti-neutrophil cytoplasmic autoantibody (ANCA) profiles in propylthiouracil-induced lupus-like manifestations in monozygotic triplets with hyperthyroidism. Scand J Rheumatol. 2002; 31(1):46-9. DOI: 10.1080/030097402317255381. View

4.
Bonaci-Nikolic B, Nikolic M, Andrejevic S, Zoric S, Bukilica M . Antineutrophil cytoplasmic antibody (ANCA)-associated autoimmune diseases induced by antithyroid drugs: comparison with idiopathic ANCA vasculitides. Arthritis Res Ther. 2005; 7(5):R1072-81. PMC: 1257438. DOI: 10.1186/ar1789. View

5.
Rubin R . Autoantibody specificity in drug-induced lupus and neutrophil-mediated metabolism of lupus-inducing drugs. Clin Biochem. 1992; 25(3):223-34. DOI: 10.1016/0009-9120(92)90354-u. View